Literature DB >> 22045397

Classification of cirrhosis: the clinical use of HVPG measurements.

Agustín Albilllos1, Guadalupe Garcia-Tsao.   

Abstract

The modern paradigm considers cirrhosis as a dynamic and potentially reversible disease. It consists of two different entities, compensated and decompensated cirrhosis, each with a distinct prognosis and different predictors of survival. The development of portal hypertension is a hallmark in the history of cirrhosis, and its progression parallels that of the disease. In consequence, portal pressure measurement by means of HVPG allows stratifying cirrhosis in stages with defined outcomes, prognosis, and management strategies.

Entities:  

Mesh:

Year:  2011        PMID: 22045397      PMCID: PMC3826926          DOI: 10.3233/DMA-2011-0834

Source DB:  PubMed          Journal:  Dis Markers        ISSN: 0278-0240            Impact factor:   3.434


  19 in total

1.  Correlation of aspartate aminotransferase/platelet ratio index with hepatic venous pressure gradient in cirrhosis.

Authors:  Vipin Verma; Shiv Kumar Sarin; Praveen Sharma; Ashish Kumar
Journal:  United European Gastroenterol J       Date:  2014-06       Impact factor: 4.623

2.  Portal hypertension in patients with cirrhosis: indirect assessment of hepatic venous pressure gradient by measuring azygos flow with 2D-cine phase-contrast magnetic resonance imaging.

Authors:  Hervé Gouya; Sophie Grabar; Olivier Vignaux; Anastasia Saade; Stanislas Pol; Paul Legmann; Philippe Sogni
Journal:  Eur Radiol       Date:  2015-09-15       Impact factor: 5.315

3.  Usefulness of portal vein pressure for predicting the effects of tolvaptan in cirrhotic patients.

Authors:  Ai Nakagawa; Masanori Atsukawa; Akihito Tsubota; Chisa Kondo; Tomomi Okubo; Taeang Arai; Norio Itokawa; Yoshiyuki Narahara; Katsuhiko Iwakiri
Journal:  World J Gastroenterol       Date:  2016-06-07       Impact factor: 5.742

Review 4.  Staging of liver fibrosis or cirrhosis: The role of hepatic venous pressure gradient measurement.

Authors:  Ki Tae Suk; Dong Joon Kim
Journal:  World J Hepatol       Date:  2015-03-27

Review 5.  Natural history of cirrhosis.

Authors:  Sumeet K Asrani; Patrick S Kamath
Journal:  Curr Gastroenterol Rep       Date:  2013-02

Review 6.  Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes.

Authors:  Francesco Vizzutti; Filippo Schepis; Umberto Arena; Fabrizio Fanelli; Stefano Gitto; Silvia Aspite; Laura Turco; Gabriele Dragoni; Giacomo Laffi; Fabio Marra
Journal:  Intern Emerg Med       Date:  2020-01-09       Impact factor: 3.397

Review 7.  Cirrhosis and portal hypertension: The importance of risk stratification, the role of hepatic venous pressure gradient measurement.

Authors:  Vincenzo La Mura; Antonio Nicolini; Giulia Tosetti; Massimo Primignani
Journal:  World J Hepatol       Date:  2015-04-08

8.  Non-invasive aspartate aminotransferase to platelet ratio index correlates well with invasive hepatic venous pressure gradient in cirrhosis.

Authors:  Vijendra Kirnake; Anil Arora; Praveen Sharma; Mohan Goyal; Romesh Chawlani; Jay Toshniwal; Ashish Kumar
Journal:  Indian J Gastroenterol       Date:  2018-09-03

Review 9.  Peculiar characteristics of portal-hepatic hemodynamics of alcoholic cirrhosis.

Authors:  Massimo Bolognesi; Alberto Verardo; Marco Di Pascoli
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

10.  Role of systemic inflammation in cirrhosis: From pathogenesis to prognosis.

Authors:  Melisa Dirchwolf; Andrés Eduardo Ruf
Journal:  World J Hepatol       Date:  2015-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.